Table 3.
Unadjusted and Adjusted Generalized Linear Mixed-Effects Modeling Logistic Regression of Factors Associated with Cannabis Use for Harm Reduction Among 1281 People Who Use Cannabis (3161 Observations), Vancouver Canada, 2016–2018
| Characteristics |
Unadjusted
|
Adjusteda
|
||
|---|---|---|---|---|
| Odds ratio (95% CI) | p | Odds ratio (95% CI) | p | |
| Sociodemographic characteristics | ||||
| Age (per year older) | 0.98 (0.97–0.98) | <0.001 | 0.98 (0.96–0.99) | 0.001 |
| Male sex | 0.82 (0.65–1.03) | 0.092 | 0.85 (0.67–1.07) | 0.165 |
| White race | 1.03 (0.83–1.28) | 0.804 | ||
| High school education or higher | 0.88 (0.71–1.10) | 0.274 | ||
| Comorbidities | ||||
| Pain severityb | 1.01 (0.97–1.05) | 0.555 | ||
| Pain interferencec | 1.00 (0.97–1.04) | 0.903 | ||
| Substance-use related factorsd | ||||
| ≥Daily heroin injection | 1.11 (0.84–1.46) | 0.479 | ||
| ≥Daily cocaine injection | 0.99 (0.54–1.81) | 0.972 | ||
| ≥Daily noninjection crack use | 1.30 (0.86–1.97) | 0.213 | ||
| ≥Daily methamphetamine use | 1.58 (1.23–2.04) | <0.001 | 1.39 (1.07–1.81) | 0.015 |
| ≥Daily nonmedical use of prescription opioids | 1.51 (0.87–2.64) | 0.146 | ||
| High-risk drinking | 0.84 (0.64–1.11) | 0.218 | ||
| Cannabis-use related factorsa | ||||
| ≥Daily cannabis use | 1.49 (1.21–1.84) | <0.001 | 1.42 (1.14–1.78) | 0.002 |
| Unregulated dispensary as primary source of cannabis | 1.58 (1.25–1.99) | <0.001 | 1.41 (1.10–1.81) | 0.007 |
| Health care-related factorsd | ||||
| Enrollment in addiction care (ref: none) | ||||
| OAT | 0.98 (0.78–1.23) | 0.851 | 1.01 (0.80–1.28) | 0.914 |
| Other modalities (e.g., detox, psychosocial, residential treatment) | 1.91 (1.39–2.63) | <0.001 | 1.65 (1.20–2.29) | 0.002 |
| Experiencing barriers to accessing addiction treatment | 2.34 (1.52–3.62) | <0.001 | 2.02 (1.30–3.14) | 0.002 |
| Social-structural factorsd | ||||
| Homelessness | 1.28 (1.02–1.61) | 0.037 | 0.94 (0.73–1.21) | 0.623 |
| Incarceration | 0.94 (0.64–1.37) | 0.738 | ||
Also adjusted for cohort designation.
In the week before questionnaire administration.
In the 24 h before questionnaire administration.
In the 6-month period before the baseline interview.